References

Bakry, R., R.M. Vallant, M. Najam-ul-Haq, M. Rainer and Z. Szabo et al., 2017. Medicinal applications of fullerenes. Intl. J. Nanomed., 2: 639-649.
PubMed  |  

Conti, M., V. Tazzari, C. Baccini, G. Pertici and L.P. Serino et al., 2006. Anticancer drug delivery with nanoparticles. Vivo, 20: 697-701.
PubMed  |  Direct Link  |  

Fan, J., G. Fang, F. Zeng, X. Wang and S. Wu, 2013. Water‐dispersible fullerene aggregates as a targeted anticancer prodrug with both Chemo and photodynamic therapeutic actions. Small, 9: 613-621.
PubMed  |  Direct Link  |  

Gabriel, M.A., T. Deutsch and A.A. Franco, 2010. Fullerene-based materials as catalysts for fuel cells. ECS. Trans., 25: 1-6.
CrossRef  |  Direct Link  |  

Guo, T., C. Jin and R.E. Smalley, 1991. Doping bucky: Formation and properties of Boron-doped buckminsterfullerene. J. Phys. Chem., 95: 4948-4950.
CrossRef  |  Direct Link  |  

Kroto, H.W., J.R. Heath, S.C. O'Brien, R.F. Curl and R.E. Smalley, 1985. C60: Buckminsterfullerene. Nat., 318: 162-163.
Direct Link  |  

Raissi, H., A. Khanmohammadi, M. Yoosefian and F. Mollania, 2013. Ab initio and DFT studies on 1-(Thionitrosomethylene) hydrazine: Conformers, energies and intramolecular hydrogen-bond strength. Struct. Chem., 24: 1121-1133.
Direct Link  |  

Shi, J., H. Zhang, L. Wang, L. Li and H. Wang et al., 2013. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials, 34: 251-261.
CrossRef  |  

Singh, R. and J.W. Lillard Jr., 2009. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., 86: 215-223.
CrossRef  |  

Wendt, M. and F. Weinhold, 2001. NBOView 1.0. Master Thesis, Theoretical Chemistry Institute, University of Wisconsin-Madison, Madison, Wisconsin.

de Jong, W.H. and P.J.A. Born, 2008. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed., 3: 133-149.
CrossRef  |  PubMed  |  Direct Link  |